A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
Public ClinicalTrials.gov record NCT00702143. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Parallel Group, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-45 in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
Study identification
- NCT ID
- NCT00702143
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Avid Radiopharmaceuticals
- Industry
- Enrollment
- 184 participants
Conditions and interventions
Conditions
Interventions
- florbetapir F 18 Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2008
- Primary completion
- Nov 30, 2008
- Completion
- Nov 30, 2008
- Last update posted
- May 9, 2012
2008
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85006 | — |
| Research Site | Scottsdale | Arizona | 85252 | — |
| Research Site | Sun City | Arizona | 85210 | — |
| Research Site | Tucson | Arizona | 85741 | — |
| Research Site | Costa Mesa | California | 92626 | — |
| Research Site | New Haven | Connecticut | 06510 | — |
| Research Site | Hallandale | Florida | 33064 | — |
| Research Site | Miami Beach | Florida | 33140 | — |
| Research Site | St. Petersburg | Florida | 33702 | — |
| Research Site | Sunrise | Florida | 33351 | — |
| Research Site | West Palm Beach | Florida | 33407 | — |
| Research Site | Albany | New York | 12208 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Jenkintown | Pennsylvania | 19046 | — |
| Research Site | Bennington | Vermont | 05201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00702143, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2012 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00702143 live on ClinicalTrials.gov.